Serum Institute of India (SII) has sought government approval for emergency use authorisation of the Covid-19 vaccine that it is developing with the University of Oxford and British drugmaker AstraZeneca.
SII's Chief Executive Officer Adar Poonawalla today took to Twitter to thank Government of India and PM Narendra Modi for their invaluable support."As promised, before the end of 2020, Serum Institute of India has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD.